Assessment of the effects of naringenin-type flavanones in uterus and vagina

Journal of Steroid Biochemistry and Molecular Biology

Volumn 145, Issue , 2015, Pages 49-57

  Keiler, Annekathrin Martina ^a   Dörfelt, Peggy ^a   Chatterjee, Namita ^b   Helle, Janina ^a   Bader, Manuela I ^a   Vollmer, Günter ^a   Kretzschmar, Georg ^a   Kuhlee, Franziska ^a   Thieme, Detlef ^a   Zierau, Oliver ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY AT ALBANY   (United States)

Author keywords

17 Estradiol; 6 (1,1 Dimethylallyl)naringenin; 8 Prenylnaringenin; Estrogenicity; Naringenin; Uterus; Vagina

Indexed keywords

6 (1,1 DIMETHYLALLY) NARINGENIN; 8 PRENYLNARINGENIN; CYCLINE; ESTRADIOL; FLAVANONE DERIVATIVE; NARINGENIN; UNCLASSIFIED DRUG; 8-PRENYLNARINGENIN; ESTROGEN; PHYTOESTROGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ENDOMETRIUM; FEMALE; GENE EXPRESSION; GENITAL SYSTEM; HUMAN; HUMAN CELL; HYDROXYLATION; LIVER MICROSOME; MENOPAUSAL SYNDROME; METABOLITE; NONHUMAN; POSTMENOPAUSE; RAT; SAFETY; UTERUS; VAGINA; VAGINA EPITHELIUM; ANIMAL; DRUG EFFECTS; EPITHELIUM; LEWIS RAT; SPRAGUE DAWLEY RAT;

ANIMALS; CELL PROLIFERATION; EPITHELIUM; ESTRADIOL; ESTROGENS; FEMALE; FLAVANONES; HUMANS; MICROSOMES, LIVER; PHYTOESTROGENS; RATS; RATS, INBRED LEW; RATS, SPRAGUE-DAWLEY; UTERUS; VAGINA;

EID: 84908214884     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2014.10.001     Document Type: Article

References (65)

1. H.D. Nelson Menopause Lancet 371 2008 760 770 10.1016/S0140-6736(08)60346-3
2. V. Beral, E. Banks, and G. Reeves Evidence from randomised trials on the long-term effects of hormone replacement therapy Lancet 360 2002 942 944 10.1016/S0140-6736(02)11032-4
3. G.L. Anderson, H.L. Judd, and A.M. Kaunitz Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the women's health initiative randomized trial JAMA 290 2003 1739 1748 10.1001/jama.290.13.1739
4. J.E. Manson, R.T. Chlebowski, and M.L. Stefanick Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the women's health initiative randomized trials J. Am. Med. Assoc. 310 2013 1353 1368 10.1001/jama.2013.278040
5. M. Bedell The pros and cons of plant estrogens for menopause J. Steroid Biochem. Mol. Biol. 139 2014 225 236 10.1016/j.jsbmb.2012.12.00
6. V.S. Lagari, and S. Levis Phytoestrogens for menopausal bone loss and climacteric symptoms J. Steroid Biochem. Mol. Biol. 139 2014 294 301 10.1016/j.jsbmb.2012.12.002
7. A.L. Ososki, and E.J. Kennelly Phytoestrogens: a review of the present state of research Phytother. Res. 17 2003 845 869 10.1002/ptr.1364
8. M.F. Ruh, T. Zacharewski, K. Connor, J. Howell, I. Chen, and S. Safe Naringenin: a weakly estrogenic bioflavonoid that exhibits antiestrogenic activity Biochem. Pharmacol. 50 1995 1485 1493 10.1016/0006-2952(95)2061-6
9. C. Felgines, O. Texier, C. Morand, C. Manach, A. Scalbert, and F. Régerat Bioavailability of the flavanone naringenin and its glycosides in rats Am. J. Physiol. - Gastrointest. Liver Physiol. 279 2000 G1148 G1154
10. O. Zierau, S. Gester, P. Schwab, P. Metz, S. Kolba, and M. Wulf Estrogenic activity of the phytoestrogens naringenin, 6-(1,1-dimethylallyl) naringenin and 8-prenylnaringenin Planta Med. 68 2002 449 451 10.1055/s-2002-32089
11. I. Erlund Review of the flavonoids quercetin, hesperetin, and naringenin. Dietary sources, bioactivities, bioavailability, and epidemiology Nutr. Res. 24 2004 851 874 10.1016/j.nutres.2004.07.005
12. O. Zierau, J. Hamann, S. Tischer, P. Schwab, P. Metz, and G. Vollmer Naringenin-type flavonoids show different estrogenic effects in mammalian and teleost test systems Biochem. Biophys. Res. Commun. 326 2005 909 916 10.1016/j.bbrc.2004.11.124
13. G. Kretzschmar, O. Zierau, J. Wober, S. Tischer, P. Metz, and G. Vollmer Prenylation has a compound specific effect on the estrogenicity of naringenin and genistein J. Steroid Biochem. Mol. Biol. 118 2010 1 6 10.1016/j.jsbmb.2009.08.005
14. J.M. Assini, E.E. Mulvihill, and M.W. Huff Citrus flavonoids and lipid metabolism Curr. Opin. Lipidol. 24 2013 34 40 10.1097/MOL.0b013e32835c07fd
15. E. Meiyanto, A. Hermawan, and Anindyajati Natural products for cancer-targeted therapy: citrus flavonoids as potent chemopreventive agents Asian Pac. J. Cancer Prev. 13 2012 427 436
16. J.C. Milligan, A. Kalita, H. Heyerick, and L.D. Rong Identification of a potent phytoestrogen in hops (Humulus lupulus L.) and beer Drug Metab. Dispos. 83 1999 2249 2252
17. J.C. Milligan, V. Kalita, V.V.D. Pocock, and J.F. Kauter The endocrine activities of 8-prenylnaringenin and related hop (Humulus lupulus L.) flavonoids J. Clin. Endocrinol. Metab. 85 2000 4912 4915 10.1210/jc.85.12.4912
18. O. Schaefer, M. Hümpel, R. Fritzemeier, and W-D Schleuning, 8-prenyl naringenin is a potent ERü selective phytoestrogen present in hops and beer J. Steroid Biochem. Mol. Biol. 84 2003 359 360 10.1016/S0960-0760(03)50-5
19. K.E. Effenberger, S.A. Johnsen, D.G. Monroe, T.C. Spelsberg, and J.J. Westendorf Regulation of osteoblastic phenotype and gene expression by hop-derived phytoestrogens J. Steroid Biochem. Mol. Biol. 96 2005 387 399 10.1016/j.jsbmb.2005.04.038
20. L.G. Ming, B.F. Ge, M.G. Wang, and K.M. Chen Comparison between 8-prenylnarigenin and narigenin concerning their activities on promotion of rat bone marrow stromal cells' osteogenic differentiation in vitro Cell Prolif. 45 2012 508 515 10.1111/j 1365-2184.2012.00844.x
21. X. Ming, X.-N. Ma, P. Ge, and P. Song The prenyl group contributes to activities of phytoestrogen 8-prenynaringenin in enhancing bone formation and inhibiting bone resorption in vitro Endocrinol. 154 2013 1202 1214 10.1210/en.2012-2086
22. M. Hümpel, P. Isaksson, O. Schaefer, U. Kaufmann, P. Ciana, and A. Maggi Tissue specificity of 8-prenylnaringenin: protection from ovariectomy induced bone loss with minimal trophic effects on the uterus J. Steroid Biochem. Mol. Biol. 97 2005 299 305 10.1016/j.jsbmb.2005.05.009
23. M. Miyamoto, Y. Matsushita, A. Kiyokawa, C. Fukuda, Y. lijima, and M. Sugano Prenylflavonoids: a new class of non-steroidal phytoestrogen (part 2). estrogenic effects of 18-isopentenylnaringenin on bone metabolism Planta Med. 64 2007 516 519 10.1055/s-2006-957505
24. S. Sehmisch, F. Hammer, J. Christoffel, D. Seidlova-Wuttke, M. Tezval, and W. Wuttke Comparison of the phytohormones genistein, resveratrol and 8-prenylnaringenin as agents for preventing osteoporosis Planta Med. 74 2008 794 801 10.1055/s-2008
25. J. Bowe, X.F. Li, J. Kinsey-Jones, A. Heyerick, S. Brain, and S. Milligan The hop phytoestrogen, 8-prenylnaringenin, reverses the ovariectomy-induced rise in skin temperature in an animal model of menopausal hot flushes J. Endocrinol. 191 2006 399 405 10.1677/joe.1.06919
26. A. Heyerick, S. Vervarcke, H. Depypere, M. Bracke, and D.D. Keukeleire A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts Maturitas 54 2006 164 175 10.1016/j.maturitas.2005.10.005
27. R. Erkkola, S. Vervarcke, S. Vansteelandt, P. Rompotti, D. De Keukeleire, and A. Heyerick A randomized, double-blind, placebo-controlled, cross-over pilot study on the use of a standardized hop extract to alleviate menopausal discomforts Phytomedicine 17 2010 389 396 10.1016/j.phymed.2010.01.007
28. E.-K.G.L. Seo, Silva, T.E. Chai, N.R. Chagwedera, and G.A. Cordell Cytotoxic prenylated flavanones from Monotes engleri Phytochemistry 45 1997 509 515 10.1016/S0031-9422(96)871-0
29. J. Wober, I. Weißwange, and G. Vollmer Stimulation of alkaline phosphatase activity in Ishikawa cells induced by various phytoestrogens and synthetic estrogens J. Steroid Biochem. Mol. Biol. 83 2002 227 233 10.1016/S0960-0760(02)252-2
30. O. Zierau, R.-B. Geis, S. Tischer, P. Schwab, P. Metz, and G. Vollmer Uterine effects of the phytoestrogen 6-(1,1-dimethylallyl) naringenin in rats Planta Med. 70 2004 590 593 10.1055/s-2004-827178
31. O. Zierau, G. Kretzschmar, F. Möller, C. Weigt, and G. Vollmer Time dependency of uterine effects of naringenin type phytoestrogens in vivo Mol. Cell Endocrinol. 294 2008 92 99 10.1016/j.mce.2008.08.008
32. OECD, Test No. 440: Uterotrophic Bioassay in Rodents: A short-term screening test for oestrogenic properties, OECD Guidelines for the Testing of Chemicals, 21, 2007, http://dx.doi.org/10.1787/9789264067417-en.
33. S. Gester, P. Metz, O. Zierau, and G. Vollmer An efficient synthesis of the potent phytoestrogens 8-prenylnaringenin and 6-(1,1-dimethylallyl) naringenin by europium(III)-catalyzed Claisen rearrangement Tetrahedron 57 2001 1015 1018 10.1016/S0040-4020(00)1078-4
34. M.W. Pfaffl A new mathematical model for relative quantification in real-time RT-PCR Nucleic Acids Res. 29 2001
35. J. Ashby, J. Odum, and J.R. Foster Activity of raloxifene in immature and ovariectomized rat uterotrophic assays Regul. Toxicol. Pharmacol. 25 1997 226 231 10.1006/rtph.1997
36. K.-S. Kang, H.-S. Kim, D.-Y. Ryu, J.-H. Che, and Y.-S. Lee Immature uterotrophic assay is more sensitive than ovariectomized uterotrophic assay for the detection of estrogenicity of p-nonylphenol in Sprague-Dawley rats Toxicol. Lett. 118 2000 109 115 10.1016/S0378-4274(00)272
37. A.D. Papaconstantinou, T.H. Umbreit, B.R. Fisher, P.L. Goering, N.T. Lappas, and K.M. Brown Bisphenol A-induced increase in uterine weight and alterations in uterine morphology in ovariectomized b6c3f1 mice: role of the estrogen receptor Toxicol. Sci. 56 2000 332 339 10.1093/toxsci/56.2
38. W. Owens, J. Ashby, J. Odum, and L. Onyon The OECD program to validate the rat uterotrophic bioassay. Phase 2: dietary phytoestrogen analyses Environ. Health Perspect. 111 2003 1559 1567
39. P. Diel, S. Schmidt, G. Vollmer, P. Janning, A. Upmeier, and H. Michna Comparative responses of three rat strains (DA/Han Sprague-Dawley and Wistar) to treatment with environmental estrogens Arch. Toxicol. 78 2004 183 193 10.1007/s00204-003-0535-y
40. R.R. Eason, S.R. Till, M.C. Velarde, Y. Geng, L. Chatman Jr., and L. Gu Uterine phenotype of young adult rats exposed to dietary soy or genistein during development J. Nutr. Biochem. 16 2005 625 632 10.1016/j.jnutbio.2005.03.005
41. G.H. Schmidt, J. Degen, T. Seibel, and G. Hertrampf Hormonal activity of combinations of genistein, bisphenol A and 17β-estradiol in the female Wistar rat Arch. Toxicol. 80 2006 839 845 10.1007/s00204-006-0102-4
42. B.A. Lessey, A.P. Killam, D.A. Metzger, A.F. Haney, G.L. Greene, and K.S. McCarty Jr. Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle J. Clin. Endocrinol. Metab. 67 1988 334 340
43. L. Sahlin, B. Masironi, S. Akerberg, and H. Eriksson Tissue- and hormone- dependent progesterone receptor distribution in the rat uterus Reprod. Biol. Endocrinol. 4 2006 47 10.1186/1477-7827-4-47
44. T.D. Charlier Importance of steroid receptor coactivators in the modulation of steroid action on brain and behavior Psychoneuroendocrinology 34 Suppl. 1 2009 S20 S29 10.1016/j.psyneuen.2009.05.004
45. T.A. Tibbetts, M. Mendoza-Meneses, B.W. O'Malley, and O.M. Conneely Mutual and intercompartmental regulation of estrogen receptor and progesterone receptor expression in the mouse uterus Biol. Reprod. 59 1998 1143 1152 10.1095/biolreprod59.5.1143
46. B. Wang, and H. Masironi A comparative study of estrogen receptors α and β in the rat uterus Biol. Reprod. 61 1999 955 964 10.1095/biolreprod61.4.955
47. P. Diel, R.-B. Geis, A. Caldarelli, S. Schmidt, U.L. Leschowsky, and A. Voss The differential ability of the phytoestrogen genistein and of estradiol to induce uterine weight and proliferation in the rat is associated with a substance specific modulation of uterine gene expression Mol. Cell. Endocrinol. 221 2004 21 32 10.1016/j.mce.2004.04.006
48. F.J. Möller, O. Zierau, T. Hertrampf, A. Bliedtner, P. Diel, and G. Vollmer Long-term effects of dietary isoflavones on uterine gene expression profiles J. Steroid Biochem. Mol. Biol. 113 2009 296 303 10.1016/j.jsbmb.2009.01.016
49. V. Breinholt, and J.C. Larsen Detection of weak estrogenic flavonoids using a recombinant yeast strain and a modified mcf7 cell proliferation assay Chem. Res. Toxicol. 11 1998 622 629 10.1021/tx970170y
50. R.S.R. Zand, D.J.A. Jenkins, and E.P. Diamandis Steroid hormone activity of flavonoids and related compounds Breast Cancer Res. Treat. 49 2000 35 49 10.1023/A.1006422302173
51. W.N. Jefferson, E. Padilla-Banks, G. Clark, and R.R. Newbold Assessing estrogenic activity of phytochemicals using transcriptional activation and immature mouse uterotrophic responses J. Chromatogr. B 777 2002 179 189 10.1016/S1570-0232(02)493-2
52. S. Kim, and T.I. Park Naringenin: a partial agonist on estrogen receptor in T47D-KBluc breast cancer cells Int. J. Clin. Exp. Med. 6 2013 890 899
53. D.A.M. Amer, G. Kretzschmar, N. Müller, N. Stanke, D. Lindemann, and G. Vollmer Activation of transgenic estrogen receptor-beta by selected phytoestrogens in a stably transduced rat serotonergic cell line J. Steroid Biochem. Mol. Biol. 120 2010 208 217 10.1016/j.jsbmb.2010.04.018
54. S.-L. Hsiu, T.-Y. Huang, Y.-C. Hou, D.-H. Chin, and P.-D.L. Chao Comparison of metabolic pharmacokinetics of naringin and naringenin in rabbits Life Sci. 70 2002 1481 1489
55. T. Fang, Y. Wang, Y. Ma, W. Su, and Y.P. Bai Zhao A rapid LC/MS/MS quantitation assay for naringin and its two metabolites in rats plasma J. Pharm. Biomed. Anal. 40 2006 454 459 10.1016/j.jpba.2005.07.031
56. M. Rad, M. Humpel, O. Schaefer, R.C. Schoemaker, W.-D. Schleuning, and A.F. Cohen Pharmacokinetics and systemic endocrine effects of the phyto-oestrogen 8-prenylnaringenin after single oral doses to postmenopausal women Br. J. Clin. Pharmacol. 62 2006 288 296 10.1111/j.1365-2125.2006.02656.x
57. G. Williamson, D. Barron, K. Shimoi, and J. Terao In vitro biological properties of flavonoid conjugates found in vivo Free Radic. Res. 39 2005 457 469 10.1080/10715760500053610
58. S.E. Nielsen, V. Breinholt, U. Justensen, C. Cornett, and L.O. Dragsted In vitro biotransformation of flavonoids by rat liver microsomes Xenobiotica 28 1998 389 401
59. D. Nikolic, and R.B. van Breemen New Metabolic pathways for flavanones catalyzed by rat liver microsomes Drug Metab. Dispos. 32 2004 387 397 10.1124/dmd.32.4.387
60. D. Nikolic, Y. Li, L.R. Chadwick, S. Grubjesic, and P.P. Schwab Metz Metabolism of 8-Prenylnaringenin, a potent phytoestrogen from hops (humulus lupulus), by human liver microsomes Drug Metab. Dispos. 32 2004 272 279 10.1124/dmd.32.2.272
61. G. Rimoldi, J. Christoffel, and W. Wuttke Morphologic changes induced by oral long-term treatment with 8-prenylnaringenin in the uterus, vagina, and mammary gland of castrated rats Menopause 13 July/August 2006 669 677 10.1097/01gme.00009690076.d0
62. C.R. Overk, J. Guo, L.R. Chadwick, D.D. Lantvit, A. Minassi, and G. Appendino In vivo estrogenic comparisons of Trifolium pratense, Humulus lupulus (hops), and the pure compounds isoxanthohumol and 8-prenylnaringenin Chem. Biol. Interact. 176 2008 30 39 10.1016/j.cbi.2008.06.005
63. C.A. Finn, and L. Martin Endocrine control of gland proliferation in the mouse uterus Biol Reprod. 8 1973 585 588
64. S. Milligan, J. Kalita, V. Pocock, A. Heyerick, L.D. Cooman, and H. Rong Oestrogenic activity of the hop phyto-oestrogen, 8-prenylnaringenin Reproduction 123 2002 235 242 10.1530/rep.0.1230235
65. J. Helle, K. Kräker, M.I. Bader, A.M. Keiler, O. Zierau, and G. Vollmer Assessment of the proliferative capacity of the flavanones 8-Prenylnaringenin, 6-(1,1-dimethylallyl) naringenin and naringenin in MCF-7 cells and the rat mammary gland Mol. Cell. Endocrinol. 2014 10.1016/j.mce.2014.05.014